A special section on the Opiate Crisis: Novel Therapeutics Directions for Opioid Use Disorder and Pain Beyond Opioids is being planned for publication in the November 2019 issue of The Journal of Pharmacology and Experimental Therapeutics.

The submission deadline is March 1, 2019.

Original research pertaining to the pharmacodynamic, pharmacokinetic, translational pharmacology, and phase 2/3 clinical trials of emerging therapeutic modalities, including (but not limited to) small molecules, antibodies, oligonucleotides, vaccines, and viral or gene-based therapies, will define the core area of interest for this special section. Manuscripts describing efforts to apply novel in vitro, in vivo, or modeling approaches to characterizing the pharmacodynamics/pharmacokinetic properties of these novel therapeutic modalities are highly encouraged. Research papers pertaining to translational medicine or the efficacy and safety of novel therapeutics in phase 2/3 trials is also highly encouraged.

Review articles addressing any aspects of the pharmacodynamics, pharmacokinetic, preclinical models, or translational medicine paradigms addressing the aforementioned therapeutic modalities will be considered as well; proposals for such articles should be sent to the guest editors: Gerard Marek, Kathryn Cunningham, and Kurt Rasmussen for approval prior to submission.